<DOC>
	<DOCNO>NCT01714427</DOCNO>
	<brief_summary>The purpose study investigate local systemic inflammatory response haemostatic alteration lung lipopolysaccharide ( LPS ) instillation determine feasibility image technique quantify lung inflammation adapt human endotoxin instillation model . The investigator also explore whether glucocorticoid treatment blunt LPS effect .</brief_summary>
	<brief_title>Validation Lung Inflammation Model Healthy Volunteers Radiological Tools Glucocorticoid Treatment</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Signed informed consent obtain trialrelated activity . ( Trial activity procedure would perform normal management subject ) . Nonsmoker Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal laboratory value unless investigator considers abnormality clinically irrelevant If female childbearing potential subject agree employ adequate birth control measure ( e. g. oral contraceptive , barrier method ) Negative urine pregnancy test Known suspect allergy trial product relate product Pregnancy Lactation Treatment investigational drug within three week prior trial Participation LPS trial within last 6 week Smoking History relevant cardiac arrhythmia Preexisting open close angle glaucoma History Osteoporosis , CushingÂ´s syndrome , gastroduodenal ulcera , cardiovascular disease , vasculitis , diabetes mellitus , hypertension , brain tumor history neurosurgery Systemic tuberculosis Hemorrhagic diathesis Relevant liver kidney dysfunction Regular use medication abuse alcohol unless consider clinically relevant Use medication within one week prior first trial day Symptoms clinically relevant illness 3 week first trial day Excessive sporting activity Rosacea Subjects Monoamine oxidase inhibitor ( stop least two three week dihydrocodeine treatment initiate ) Known acute active hepatic disease within past 3 month A platelet count &lt; 100,000 x 106/L , prothrombin time &gt; 1.5 , liver enzymes &gt; 3 time upper normal limit Having receive vaccination 8 week trial</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>